Monday, November 7, 2016

BRIEF-Kedrion Biopharma and Kamada announce FDA acceptance of BLA submission

* Says FDA has assigned a prescription drug user fee act

(PDUFA) goal date of August 29, 2017, for completion of review

of BLA

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)